Toll Free: 1-888-928-9744
Published: Jul, 2015 | Pages:
25 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Interprotein Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Interprotein Corporation - Product Pipeline Review - 2015', provides an overview of the Interprotein Corporation's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Interprotein Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Interprotein Corporation including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Interprotein Corporation's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Interprotein Corporation's pipeline products Reasons to buy - Evaluate Interprotein Corporation's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Interprotein Corporation in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Interprotein Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Interprotein Corporation and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Interprotein Corporation - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Interprotein Corporation and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Interprotein Corporation Snapshot 4 Interprotein Corporation Overview 4 Key Information 4 Key Facts 4 Interprotein Corporation - Research and Development Overview 5 Key Therapeutic Areas 5 Interprotein Corporation - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Partnered Products 9 Partnered Products/Combination Treatment Modalities 10 Pipeline Products - Out-Licensed Products 11 Out-Licensed Products/Combination Treatment Modalities 12 Interprotein Corporation - Pipeline Products Glance 13 Interprotein Corporation - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Interprotein Corporation - Drug Profiles 15 IPC-003 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 IPZ-010 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Small Molecule to Inhibit VEGF for Oncology 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Small Molecule to Inhibit IgE for Allergies 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Interprotein Corporation - Pipeline Analysis 19 Interprotein Corporation - Pipeline Products by Target 19 Interprotein Corporation - Pipeline Products by Molecule Type 20 Interprotein Corporation - Pipeline Products by Mechanism of Action 21 Interprotein Corporation - Recent Pipeline Updates 22 Interprotein Corporation - Locations And Subsidiaries 23 Head Office 23 Other Locations & Subsidiaries 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 24 Disclaimer 25
List of Tables
Interprotein Corporation, Key Information 4 Interprotein Corporation, Key Facts 4 Interprotein Corporation - Pipeline by Indication, 2015 6 Interprotein Corporation - Pipeline by Stage of Development, 2015 7 Interprotein Corporation - Monotherapy Products in Pipeline, 2015 8 Interprotein Corporation - Partnered Products in Pipeline, 2015 9 Interprotein Corporation - Partnered Products/ Combination Treatment Modalities, 2015 10 Interprotein Corporation - Out-Licensed Products in Pipeline, 2015 11 Interprotein Corporation - Out-Licensed Products/ Combination Treatment Modalities, 2015 12 Interprotein Corporation - Preclinical, 2015 13 Interprotein Corporation - Discovery, 2015 14 Interprotein Corporation - Pipeline by Target, 2015 19 Interprotein Corporation - Pipeline by Molecule Type, 2015 20 Interprotein Corporation - Pipeline Products by Mechanism of Action, 2015 21 Interprotein Corporation - Recent Pipeline Updates, 2015 22 Interprotein Corporation, Other Locations 23
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.